 In cancer research, some types of tumors have distinctive mutational signatures that reflect differences in the contributions of mutational pathways.Mutational signatures have proved useful in both detection and treatment.Recent studies of the emergence of resistance to anti-microbials and anti-cancer drugs show that mutation biases are an important determinant of the prevalence for different types of resistant strains or tumors.